Literature DB >> 19150103

Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene.

Audrey Low1, Chioma M Okeoma, Nika Lovsin, Marcelo de las Heras, Thomas H Taylor, B Matija Peterlin, Susan R Ross, Hung Fan.   

Abstract

Human APOBEC3G (hA3G), a member of the AID/APOBEC family of deaminases, is a restriction factor for human immunodeficiency virus (HIV). In the absence of the viral Vif protein hA3G is packaged into virions and during reverse transcription in a recipient cell it deaminates cytosines, leading to G-->A hypermutation and inactivation of the viral DNA. Unlike humans, who carry seven APOBEC3 genes, mice only carry one, mA3. Thus the role of mA3 in restriction of retroviral infection could be studied in mA3 -/- knockout mice, where the gene is inactivated. M-MuLV-infected mA3 -/- mice showed substantially higher levels of infection at very early times compared to wild-type mice (ca. 2 logs at 0-10 days), particularly in the bone marrow and spleen. Restriction of M-MuLV infection was studied ex vivo in primary bone marrow-derived dendritic cells (BMDCs) that express or lack mA3, using an M-MuLV-based retroviral vector expressing enhanced jellyfish green fluorescent protein (EGFP). The results indicated that mA3 within the virions as well as mA3 in the recipient cell contribute to resistance to infection in BMDCs. Finally, M-MuLV-infected mA3 +/+ mice developed leukemia more slowly compared to animals lacking one or both copies of mA3 although the resulting disease was similar (T-lymphoma). These studies indicate that mA3 restricts replication and pathogenesis of M-MuLV in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150103      PMCID: PMC3124558          DOI: 10.1016/j.virol.2008.11.051

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

1.  APOBEC3 inhibits mouse mammary tumour virus replication in vivo.

Authors:  Chioma M Okeoma; Nika Lovsin; B Matija Peterlin; Susan R Ross
Journal:  Nature       Date:  2007-01-28       Impact factor: 49.962

2.  Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms.

Authors:  Aierken Abudu; Akifumi Takaori-Kondo; Taisuke Izumi; Kotaro Shirakawa; Masayuki Kobayashi; Amane Sasada; Keiko Fukunaga; Takashi Uchiyama
Journal:  Curr Biol       Date:  2006-08-08       Impact factor: 10.834

3.  Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family.

Authors:  Ying Dang; Xiaojun Wang; Walter J Esselman; Yong-Hui Zheng
Journal:  J Virol       Date:  2006-08-18       Impact factor: 5.103

4.  Critical role of dendritic cells in mouse mammary tumor virus in vivo infection.

Authors:  Maria Cecilia Courreges; Dalia Burzyn; Irene Nepomnaschy; Isabel Piazzon; Susan R Ross
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

5.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

6.  Species-specific restriction of apobec3-mediated hypermutation.

Authors:  Edward P Browne; Dan R Littman
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

7.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.

Authors:  Hui Zhang; Bin Yang; Roger J Pomerantz; Chune Zhang; Shyamala C Arunachalam; Ling Gao
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

Review 8.  APOBEC-mediated viral restriction: not simply editing?

Authors:  Rebecca K Holmes; Michael H Malim; Kate N Bishop
Journal:  Trends Biochem Sci       Date:  2007-02-15       Impact factor: 13.807

9.  Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.

Authors:  Kate N Bishop; Rebecca K Holmes; Michael H Malim
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

10.  APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.

Authors:  Marjorie Pion; Angela Granelli-Piperno; Bastien Mangeat; Romaine Stalder; Rafael Correa; Ralph M Steinman; Vincent Piguet
Journal:  J Exp Med       Date:  2006-12-04       Impact factor: 14.307

View more
  66 in total

1.  Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Authors:  Judd F Hultquist; Reuben S Harris
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

2.  In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models.

Authors:  Yuki Nakaya; Spyridon Stavrou; Kristin Blouch; Peter Tattersall; Susan R Ross
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

3.  Biochemical and biological studies of mouse APOBEC3.

Authors:  Smita Nair; Silvia Sanchez-Martinez; Xinhua Ji; Alan Rein
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

4.  APOBEC3G complexes decrease human immunodeficiency virus type 1 production.

Authors:  Kenneth L Martin; Megan Johnson; Richard T D'Aquila
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

5.  Nucleic acid recognition orchestrates the anti-viral response to retroviruses.

Authors:  Spyridon Stavrou; Kristin Blouch; Swathi Kotla; Antonia Bass; Susan R Ross
Journal:  Cell Host Microbe       Date:  2015-03-26       Impact factor: 21.023

Review 6.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

7.  BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1).

Authors:  Philip H Jones; Martina Maric; Marisa N Madison; Wendy Maury; Richard J Roller; Chioma M Okeoma
Journal:  Virology       Date:  2013-02-12       Impact factor: 3.616

8.  Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV.

Authors:  Kristin Stieler; Nicole Fischer
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

9.  APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription.

Authors:  Alyssa L MacMillan; Rahul M Kohli; Susan R Ross
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

10.  IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.

Authors:  Michael S Harper; Bradley S Barrett; Diana S Smith; Sam X Li; Kathrin Gibbert; Ulf Dittmer; Kim J Hasenkrug; Mario L Santiago
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.